Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N North

Showing results (211-220 of 333) with videos related to

Pageof 34
Sort By:
The Journal of Biological Chemistry|July 3, 2010
Reduced plasma membrane expression of dysferlin mutants is attributed to accelerated endocytosis via a syntaxin-4-associated pathwayFrances J Evesson, Rachel A Peat, Angela Lek, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 22, 2013
Calpains, cleaved mini-dysferlinC72, and L-type channels underpin calcium-dependent muscle membrane repairAngela Lek, Frances J Evesson, Frances A Lemckert, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 4, 2006
Cardiac aquaporin expression in humans, rats, and miceTanya L Butler, Carol G Au, Baoxue Yang, et al.
Neuromuscular Disorders : NMD|July 27, 2012
Mutations in TPM2 and congenital fibre type disproportionNigel F Clarke, Leigh B Waddell, Lilian T L Sie, et al.
Neuromuscular Disorders : NMD|January 22, 2002
Primary gamma-sarcoglycanopathy (LGMD 2C): broadening of the mutational spectrum guided by the immunohistochemical profileC G Bönnemann, J Wong, K J Jones, et al.
Journal of Neuropathology and Experimental Neurology|August 22, 2008
Disease severity and thin filament regulation in M9R TPM3 nemaline myopathyBiljana Ilkovski, Nancy Mokbel, Raymond A Lewis, et al.
Annals of Neurology|December 21, 2005
SEPN1: associated with congenital fiber-type disproportion and insulin resistanceNigel F Clarke, Warren Kidson, Susana Quijano-Roy, et al.
Neuromuscular Disorders : NMD|July 8, 2008
Exclusion of biglycan mutations in a cohort of patients with neuromuscular disordersRachel A Peat, Jozef Gécz, Justin R Fallon, et al.
Neurology|December 28, 2007
Diagnosis and etiology of congenital muscular dystrophyR A Peat, J M Smith, A G Compton, et al.
BMJ Open|September 1, 2018
Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trialNatalie A Pride, Belinda Barton, Paul Hutchins, et al.
Pageof 34

Showing results (211-220 of 333) with videos related to

Sort By:
Pageof 34
The Journal of Biological Chemistry|July 3, 2010
Reduced plasma membrane expression of dysferlin mutants is attributed to accelerated endocytosis via a syntaxin-4-associated pathwayFrances J Evesson, Rachel A Peat, Angela Lek, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 22, 2013
Calpains, cleaved mini-dysferlinC72, and L-type channels underpin calcium-dependent muscle membrane repairAngela Lek, Frances J Evesson, Frances A Lemckert, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 4, 2006
Cardiac aquaporin expression in humans, rats, and miceTanya L Butler, Carol G Au, Baoxue Yang, et al.
Neuromuscular Disorders : NMD|July 27, 2012
Mutations in TPM2 and congenital fibre type disproportionNigel F Clarke, Leigh B Waddell, Lilian T L Sie, et al.
Neuromuscular Disorders : NMD|January 22, 2002
Primary gamma-sarcoglycanopathy (LGMD 2C): broadening of the mutational spectrum guided by the immunohistochemical profileC G Bönnemann, J Wong, K J Jones, et al.
Journal of Neuropathology and Experimental Neurology|August 22, 2008
Disease severity and thin filament regulation in M9R TPM3 nemaline myopathyBiljana Ilkovski, Nancy Mokbel, Raymond A Lewis, et al.
Annals of Neurology|December 21, 2005
SEPN1: associated with congenital fiber-type disproportion and insulin resistanceNigel F Clarke, Warren Kidson, Susana Quijano-Roy, et al.
Neuromuscular Disorders : NMD|July 8, 2008
Exclusion of biglycan mutations in a cohort of patients with neuromuscular disordersRachel A Peat, Jozef Gécz, Justin R Fallon, et al.
Neurology|December 28, 2007
Diagnosis and etiology of congenital muscular dystrophyR A Peat, J M Smith, A G Compton, et al.
BMJ Open|September 1, 2018
Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trialNatalie A Pride, Belinda Barton, Paul Hutchins, et al.
Pageof 34